Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 0.59%2.17B | -7.97%2.31B | -3.43%1.97B | 13.94%2.46B | 7.69%2.15B | 12.15%2.51B | -28.17%2.04B | -21.30%2.16B | -26.33%2B | 0.02%2.24B |
| Transactional financial assets | 165.60%1.24M | 182.03%1.08M | 220.80%1.02M | 113.69%765.98K | 28.22%468.6K | 7.56%384.49K | -16.54%318.41K | -7.25%358.46K | -21.84%365.47K | -35.68%357.46K |
| Notes receivable and accounts receivable | 13.11%1.22B | 13.91%1.19B | 20.27%1.14B | 9.69%1.05B | 11.07%1.08B | -1.36%1.04B | -5.31%948.89M | 7.29%955.55M | 3.44%970.98M | 12.47%1.06B |
| -Notes receivable | ---- | ---- | -85.83%2.13M | 82.04%10.22M | --8.21M | ---- | 3,913.98%15.05M | 1,212.83%5.61M | ---- | -32.00%90.01K |
| -Accounts receivable | 13.98%1.22B | 13.91%1.19B | 21.98%1.14B | 9.27%1.04B | 10.22%1.07B | -1.35%1.04B | -6.78%933.84M | 6.71%949.94M | 3.52%970.98M | 12.47%1.06B |
| Other receivables (including interest and dividends) | -34.48%2.91M | -36.05%2.7M | -67.75%2.51M | -29.48%1.19M | -12.03%4.44M | 97.36%4.22M | 37.34%7.8M | -71.57%1.68M | 19.21%5.05M | -57.81%2.14M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | --2.71M | ---- | ---- | ---- |
| -Other receivable | ---- | -36.05%2.7M | ---- | ---- | ---- | 97.36%4.22M | ---- | -71.57%1.68M | ---- | -28.39%2.14M |
| Advance payment | 25.12%73M | 64.57%42.25M | 40.88%54.76M | 11.33%50.65M | 29.17%58.34M | 4.63%25.67M | 63.95%38.87M | 138.78%45.49M | 28.04%45.17M | 8.09%24.53M |
| Inventories | 29.74%1.43B | 34.92%1.42B | 22.37%1.38B | 7.52%1.19B | 11.42%1.1B | 2.86%1.06B | -7.58%1.13B | -20.66%1.11B | -24.48%987.95M | -22.81%1.03B |
| Receivable financing | 6.31%1.03B | -5.28%897.04M | -2.09%1.02B | 16.50%1.03B | -6.65%969.83M | -6.70%947.07M | 17.08%1.04B | 13.75%883.41M | 14.39%1.04B | 27.67%1.02B |
| Non-current assets due within one year | 6,466.66%1.02B | 48.31%54.15M | -7.95%53.75M | 61.72%69.02M | -63.22%15.58M | 69.69%36.51M | --58.39M | 172.94%42.68M | 172.43%42.37M | -40.79%21.51M |
| Other current assets | 2.09%7.63B | 6.42%7.9B | 6.70%7.87B | -0.47%7.54B | 0.57%7.47B | -8.42%7.42B | 10.84%7.38B | 14.56%7.58B | 17.67%7.43B | 30.23%8.1B |
| Total current assets | 13.38%14.58B | 5.93%13.81B | 6.75%13.5B | 4.84%13.39B | 2.66%12.86B | -3.30%13.04B | 0.02%12.64B | 2.50%12.78B | 2.29%12.52B | 16.39%13.48B |
| Non Current assets | ||||||||||
| Other equity investment | ---- | ---- | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M | 0.00%50M |
| Investment real estate | -13.77%1.32M | -13.31%1.37M | -12.88%1.43M | -12.48%1.48M | -12.10%1.53M | -11.74%1.58M | -11.41%1.64M | -11.09%1.69M | -10.79%1.74M | -10.51%1.79M |
| Fixed assets | ---- | -8.49%3.66B | ---- | ---- | ---- | -4.15%4B | ---- | -3.97%4.18B | ---- | -6.29%4.17B |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --25.69K |
| Constru in process | ---- | -4.30%94.4M | ---- | ---- | ---- | -54.05%98.64M | ---- | -62.54%78.99M | ---- | -17.97%214.66M |
| Intangible assets | -2.39%388.58M | -2.35%391.9M | -2.75%393.08M | -2.71%396.48M | -3.07%398.1M | -2.98%401.35M | -2.61%404.19M | -2.32%407.53M | -2.37%410.69M | -2.50%413.68M |
| Deferred tax assets | 10.48%95.56M | 10.84%95.08M | 11.82%97.73M | 17.32%94.95M | 11.51%86.5M | 5.52%85.78M | 8.88%87.4M | 6.29%80.93M | 0.41%77.57M | 4.25%81.3M |
| Usufruct assets | -37.56%26.31M | -39.10%28.92M | -36.82%33.44M | 224.30%36.3M | 120.03%42.14M | 65.08%47.49M | 42.44%52.92M | -64.76%11.19M | -49.64%19.15M | -39.06%28.77M |
| Other non current assets | -67.26%463.94M | 2.55%1.42B | 1.17%1.38B | 17.10%1.38B | 46.52%1.42B | 1,501.78%1.39B | 1,174.74%1.37B | 1,182.68%1.17B | 2,250.43%967.24M | 315.11%86.64M |
| Total non current assets | -22.65%4.65B | -6.21%5.7B | -5.33%5.8B | -1.63%5.89B | 2.85%6.01B | 20.24%6.07B | 18.60%6.13B | 14.40%5.98B | 10.87%5.84B | -5.39%5.05B |
| Total assets | 1.90%19.22B | 2.07%19.51B | 2.80%19.3B | 2.78%19.28B | 2.72%18.87B | 3.11%19.11B | 5.41%18.77B | 6.02%18.76B | 4.88%18.37B | 9.52%18.54B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -3.97%1.04B | 28.73%1.2B | 46.50%1.24B | 32.12%1.24B | 14.26%1.08B | -14.31%933.56M | -26.25%845.17M | -23.67%937.71M | -35.31%946.56M | -20.65%1.09B |
| Notes payable and accounts payable | 3.41%3.77B | 4.50%3.77B | 1.82%3.71B | -2.11%3.71B | -2.30%3.65B | -9.84%3.6B | -0.68%3.65B | -1.77%3.79B | 0.25%3.73B | 14.58%4B |
| -Notes payable | 58.35%413.74M | 83.86%436.9M | 93.74%455.82M | 52.63%359.45M | -44.24%261.29M | -67.10%237.62M | -75.04%235.27M | -80.80%235.5M | -58.67%468.6M | -30.35%722.26M |
| -Accounts payable | -0.83%3.36B | -1.10%3.33B | -4.52%3.26B | -5.73%3.35B | 3.72%3.39B | 2.79%3.37B | 25.02%3.41B | 35.02%3.56B | 26.03%3.27B | 33.59%3.27B |
| Contract liabilities | -8.17%139.69M | 37.19%126.27M | 23.18%153.14M | -17.44%151.19M | 4.81%152.11M | -32.56%92.04M | 28.12%124.32M | 70.39%183.14M | 101.61%145.13M | 84.54%136.47M |
| Salaries payable | -1.95%30.05M | -7.42%27.43M | -3.62%26.73M | -20.68%27.82M | 4.92%30.65M | 9.68%29.63M | 11.79%27.73M | 36.80%35.07M | 5.85%29.21M | 4.74%27.02M |
| Taxs payable | -5.16%48.14M | -19.79%65.97M | -10.00%64.64M | -23.50%70.28M | -40.86%50.77M | -12.09%82.25M | 14.15%71.82M | 41.41%91.87M | 86.31%85.85M | 75.25%93.56M |
| Other payable (including interest and dividends) | 4.55%112.75M | -18.39%520.37M | 2.98%110.19M | -10.46%95.6M | -19.92%107.84M | 89.64%637.6M | 16.28%107M | 25.06%106.77M | 18.38%134.66M | 19.80%336.21M |
| -Dividend payable | ---- | -20.90%424M | ---- | ---- | ---- | 139.29%536M | ---- | ---- | ---- | 21.74%224M |
| -Other payable | ---- | -5.15%96.37M | ---- | ---- | ---- | -9.45%101.6M | ---- | 25.06%106.77M | ---- | 16.10%112.21M |
| Non current liabilities due within one year | -90.65%15.81M | -95.49%16.71M | -95.05%18.36M | -18.01%168.08M | 1,371.20%169.12M | 1,529.85%370.16M | 1,053.09%370.7M | 689.76%205M | -60.86%11.5M | -36.34%22.71M |
| Other current liabilities | -25.42%3.86M | -13.96%4.52M | -16.92%4.17M | -35.86%3.06M | -17.92%5.18M | 26.59%5.26M | 32.11%5.02M | 47.22%4.77M | 63.65%6.31M | 34.06%4.15M |
| Total current liabilities | -1.60%5.16B | -0.44%5.73B | 2.50%5.33B | 2.06%5.47B | 2.99%5.25B | 0.84%5.75B | 1.33%5.2B | -0.84%5.36B | -7.06%5.09B | 6.99%5.71B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -25.00%150.13M | 75.14%350.28M | --350.28M |
| Deferred tax liabilities | -21.62%58.38M | -23.60%58.73M | -24.24%60.47M | -14.02%61.07M | 4.07%74.48M | 1.20%76.87M | 0.87%79.82M | -5.12%71.03M | -0.27%71.57M | 2.12%75.96M |
| Long term deferred income | -5.24%280.7M | -5.32%283.89M | -3.94%286.69M | -4.08%289.45M | -2.93%296.24M | -2.63%299.83M | -4.02%298.46M | -3.76%301.77M | -3.81%305.17M | -3.86%307.95M |
| Lease liabilities | -59.08%9.06M | -58.87%11.07M | -55.06%14.35M | 196.14%17.62M | 186.69%22.15M | 253.00%26.91M | 434.16%31.94M | -5.29%5.95M | -8.70%7.73M | -43.59%7.62M |
| Total non current liabilities | -11.38%348.15M | -12.37%353.7M | -11.87%361.51M | -30.39%368.15M | -46.53%392.87M | -45.59%403.62M | -45.20%410.22M | -11.09%528.89M | 22.97%734.75M | 81.73%741.81M |
| Total liabilities | -2.28%5.51B | -1.22%6.08B | 1.45%5.69B | -0.85%5.84B | -3.26%5.64B | -4.51%6.16B | -4.60%5.61B | -1.85%5.89B | -4.11%5.83B | 12.30%6.45B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%800M | 0.00%800M | 0.00%800M | 0.00%800M | 0.00%800M | 0.00%800M | 0.00%800M | 0.00%800M | 0.00%800M | 0.00%800M |
| Capital reserve funds | 0.00%5.23B | 0.00%5.23B | 0.00%5.23B | 0.00%5.23B | 0.00%5.23B | 0.00%5.23B | 0.00%5.23B | 0.00%5.23B | 0.00%5.23B | 0.00%5.23B |
| Surplus reserve funds | 0.00%1.32B | 0.00%1.32B | 0.00%1.32B | 0.00%1.32B | 15.89%1.32B | 15.89%1.32B | 15.89%1.32B | 15.89%1.32B | 5.16%1.14B | 5.16%1.14B |
| Retained profit | 8.26%6.34B | 8.39%6.05B | 7.56%6.24B | 10.28%6.08B | 9.45%5.86B | 13.94%5.59B | 22.18%5.8B | 21.94%5.51B | 24.26%5.35B | 20.93%4.9B |
| Other composite income | 15.38%27.32M | 11.04%25.57M | 35.54%23.99M | 23.07%20.8M | 14.41%23.68M | 15.35%23.03M | -4.29%17.7M | 25.53%16.9M | 16.19%20.7M | 4.26%19.96M |
| Ordinary risk reserve funds | 4.28%574.56K | 10.12%514.18K | 16.20%471.4K | 35.11%559.04K | 4.07%551K | 38.79%466.91K | 2.12%405.67K | 25.13%413.76K | 68.38%529.46K | 1.99%336.4K |
| Shareholders equity without minority interests | 3.68%13.71B | 3.64%13.42B | 3.38%13.61B | 4.43%13.44B | 5.50%13.23B | 7.18%12.95B | 10.34%13.17B | 10.05%12.87B | 9.65%12.54B | 8.10%12.09B |
| Minority interests | 26.82%1.64M | 20.45%1.47M | 14.23%1.15M | 25.69%1.31M | 41.78%1.3M | 61.71%1.22M | 68.43%1.01M | 32.30%1.04M | -5.35%913.94K | -31.49%755.56K |
| Total shareholder equity | 3.69%13.71B | 3.64%13.43B | 3.38%13.61B | 4.43%13.44B | 5.50%13.23B | 7.18%12.95B | 10.34%13.17B | 10.05%12.87B | 9.65%12.54B | 8.09%12.09B |
| Total liabilityies and equity | 1.90%19.22B | 2.07%19.51B | 2.80%19.3B | 2.78%19.28B | 2.72%18.87B | 3.11%19.11B | 5.41%18.77B | 6.02%18.76B | 4.88%18.37B | 9.52%18.54B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.